Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration
about
Evaluation of Models of Parkinson's DiseaseProgressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceParkinson's disease: animal models and dopaminergic cell vulnerabilityThe Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity.Transgenic LRRK2 (R1441G) rats-a model for Parkinson disease?LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit functionAge-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein PathologyCellular processes associated with LRRK2 function and dysfunctionCancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.LRRK2 and Autophagy.Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.Models of LRRK2-Associated Parkinson's Disease.Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice.Mechanisms of Mutant LRRK2 Neurodegeneration.Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.Characterization of New Transgenic Mouse Models for Two Charcot-Marie-Tooth-Causing HspB1 Mutations using the Rosa26 Locus.Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice.Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.
P2860
Q26772843-3D053469-0971-445C-BFC1-285BAB12F546Q27308060-A84B58D9-7089-451A-9EBD-8054F716B2F0Q28080503-A4CF5790-D194-4602-A654-C46A3C9FE586Q30357944-A23B2324-88E5-4E6A-84F6-ACC68AE66F88Q30410927-050B7130-F584-4922-AFF3-168E4D363871Q36581417-4E5C9FB7-787D-45FE-ACB8-C4F90886312CQ37701053-51DD3D76-E469-46A5-B920-750B03CB028AQ37707932-56D3FE0C-D48B-4637-A8E2-43253FE529D6Q38433725-C5C1E4C6-D808-4F36-BDEA-54B65C9868D0Q38810854-5D2DE5E6-116A-4188-884D-08C7307DBE46Q38869514-E664EA7D-7C2E-4DA7-B3FB-9457EA2CD615Q39206431-E5C6C186-D33D-4547-8436-5D2E2A6D0A0AQ39206443-A6CD2702-87A4-42A9-B3DF-BD3873C2EFEFQ47620111-B4AEDB72-B736-47CE-872E-BA1F5345EAF0Q48239635-79059E66-0742-4554-B688-CB9B1DD3A1ACQ48397481-A340AE80-DE5F-43E9-94E8-A5CC82C8BAD0Q48427387-8F373752-0114-4A1A-8A40-8490307E3DA0Q49545058-45E2DD87-3F79-4CF9-98AC-D6B2F13B0E4EQ50055669-401B47EC-D51E-4BFE-85A1-7A53D7F01147
P2860
Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Conditional expression of Park ...... ties without neurodegeneration
@ast
Conditional expression of Park ...... ties without neurodegeneration
@en
type
label
Conditional expression of Park ...... ties without neurodegeneration
@ast
Conditional expression of Park ...... ties without neurodegeneration
@en
prefLabel
Conditional expression of Park ...... ties without neurodegeneration
@ast
Conditional expression of Park ...... ties without neurodegeneration
@en
P2093
P2860
P50
P1476
Conditional expression of Park ...... ties without neurodegeneration
@en
P2093
Dagmar Galter
Dustin Dikeman
Liliane Glauser
Sandra Gellhaar
Ted M Dawson
Valina L Dawson
P2860
P304
P356
10.1016/J.NBD.2014.08.027
P577
2014-08-29T00:00:00Z